Ardelyx reported $94.47M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Amgen USD 8.62B 1.28B Mar/2026
Ardelyx USD 94.47M 30.74M Mar/2026
aTyr Pharma USD 110.08M 109.89M Dec/2025
Corcept Therapeutics USD 164.9M 37.22M Mar/2026
Curis USD 1.14M 1.41M Dec/2025
Sanofi EUR 12.14B 65M Mar/2026
TG Therapeutics USD 194.8M 2.23M Mar/2026
United Therapeutics USD 781.5M 8.7M Mar/2026
Xoma USD 25K 5M Sep/2024